Hugh Stephen Griffith News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hugh stephen griffith. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hugh Stephen Griffith Today - Breaking & Trending Today

NuCana (NASDAQ:NCNA) Trading Up 1.9%

Shares of NuCana plc (NASDAQ:NCNA – Get Rating) were up 1.9% during mid-day trading on Thursday . The company traded as high as $0.85 and last traded at $0.85. Approximately 17,878 shares changed hands during mid-day trading, a decline of 84% from the average daily volume of 111,765 shares. The stock had previously closed at […] ....

United Kingdom , City Of , Christopher Barry Wood , Hugh Stephen Griffith , Nucana Plc , Nucana Company Profile , Commonwealth Equity Services , Carlyle Group Inc , Acadian Asset Management , Virtu Financial , Renaissance Technologies , Get Rating , Asset Management , Equity Services , Nucana Plc , Nucana Daily , Nasdaq Ncna ,

Analysts Expect NuCana plc (NASDAQ:NCNA) to Announce -$0.27 EPS

Equities analysts expect NuCana plc (NASDAQ:NCNA – Get Rating) to announce earnings per share (EPS) of ($0.27) for the current quarter, according to Zacks Investment Research. Zero analysts have made estimates for NuCana’s earnings, with estimates ranging from ($0.32) to ($0.21). NuCana posted earnings per share of ($0.26) in the same quarter last year, which […] ....

United Kingdom , City Of , Hugh Stephen Griffith , Christopher Barry Wood , Goldman Sachs Group Inc , Virtu Financial , Zacks Investment Research , Nucana Plc , Moors Cabot Inc , Group Plc , Opaleye Management Inc , Get Rating , Zacks Investment , Investment Research , Sachs Group , General Group Plc , Nucana Plc , Nasdaq Ncna ,

Zacks Investment Research Lowers NuCana (NASDAQ:NCNA) to Hold

NuCana (NASDAQ:NCNA – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Friday, Zacks.com reports. According to Zacks, “NuCana PLC is a clinical-stage biopharmaceutical company. It focused on improving treatment outcomes for cancer patients by applying its phosphoramidate chemistry technology. The […] ....

United Kingdom , City Of , Hugh Stephen Griffith , Christopher Barry Wood , Wells Fargo Company , Squarepoint Ops , Moors Cabot Inc , Virtu Financial , Zacks Investment Research , Nucana Plc , Millennium Management , Get Rating , Nucana Plc , Nasdaq Ncna ,